Back to dashboard
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 2 June 2026 | AH EQUITY PARTNERS BIO II LLCVenture Capital | Sell Regular sell transaction (market) | 4,615,974 | $2.35 | $10,847,538.90 | 11,682,032 |
| 2 June 2026 | AH EQUITY PARTNERS BIO II LLCVenture Capital | Sell Regular sell transaction (market) | 384,026 | $2.35 | $902,461.10 | 971,885 |
| 6 November 2025 | Kentaro (Ken) SuzukiChief Marketing Officer | Buy Regular purchase transaction | 4,000 | $1.49 | $5,960.00 | 4,000 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 2 June 2026 | AH EQUITY PARTNERS BIO II LLCVenture Capital | Sell Regular sell transaction (market) | 4,615,974 | $2.35 | $10,847,538.90 | 11,682,032 |
| 2 June 2026 | AH EQUITY PARTNERS BIO II LLCVenture Capital | Sell Regular sell transaction (market) | 384,026 | $2.35 | $902,461.10 | 971,885 |
| 6 November 2025 | Kentaro (Ken) SuzukiChief Marketing Officer | Buy Regular purchase transaction | 4,000 | $1.49 | $5,960.00 | 4,000 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.